M6A Methylation Regulates Osteoblastic Differentiation and Bone Remodeling

Overview

Journal Front Cell Dev Biol

Specialty Cell Biology

Date 2022 Jan 7

PMID 34993198

Citations 41

Authors

Mei Huang

Shaozhe Xu

Lifei Liu

Miao Zhang

Jianmin Guo

Yu Yuan

Jiake Xu

Xi Chen

Jun Zou

Affiliations

Soon will be listed here.

Abstract

Osteoporosis is a prevalent bone disease of the aging population, which is characterized by a decrease in bone mass because of the imbalance of bone metabolism. Although the prevention and treatment of osteoporosis have been explored by different researchers, the mechanisms underlying osteoporosis are not clear exactly. N6 methyladenosine (m6A) is a methylated adenosine nucleotide, which functions through its interaction with the proteins called "writers," "readers" and "erasers." The epigenetic regulation of m6A has been demonstrated to affect mRNA processing, nuclear export, translation, and splicing. At the cellular level, m6A modification has been known to affect cell proliferation, differentiation, and apoptosis of bone-related cells, such as bone marrow mesenchymal stem cells (BMSC), osteoblasts, and osteoclasts by regulating the expression of ALP, Runx2, Osterix, VEGF, and other related genes. Furthermore, PTH/Pth1r, PI3K-Akt, Wnt/β-Catenin, and other signaling pathways, which play important roles in the regulation of bone homeostasis, are also regulated by m6A. Thus, m6A modification may provide a new approach for osteoporosis treatment. The key roles of m6A modification in the regulation of bone health and osteoporosis are reviewed here in this article.

Citing Articles

Methyltransferase-Like 3-Mediated N-Methyladenosine Modification on RNAs: A Novel Perspective for the Pathogenesis and Treatment of Bone Diseases.

Xiao D, Zhang D, Qu Y, Su X J Cell Mol Med. 2025; 29(5):e70483.

PMID: 40052548 PMC: 11886889. DOI: 10.1111/jcmm.70483.

The Emerging Role of m6A and Programmed Cell Death in Cardiovascular Diseases.

Wang H, Han J, Kong H, Ma C, Zhang X Biomolecules. 2025; 15(2).

PMID: 40001550 PMC: 11853213. DOI: 10.3390/biom15020247.

Landscape analysis of m6A modification reveals the dysfunction of bone metabolism in osteoporosis mice.

Zheng L, Lan C, Gao X, Zhu A, Chen Y, Lin J Heliyon. 2025; 11(3):e42123.

PMID: 39991256 PMC: 11847259. DOI: 10.1016/j.heliyon.2025.e42123.

FTO-associated osteoclastogenesis promotes alveolar bone resorption in apical periodontitis male rat via the HK1/USP14/RANK pathway.

Qian Y, Wu J, Yang W, Lyu R, You Q, Li J Nat Commun. 2025; 16(1):1519.

PMID: 39934129 PMC: 11814306. DOI: 10.1038/s41467-025-56615-1.

METTL14 Promotes the Osteogenic Differentiation of Human Bone Marrow Stromal Cells via m6A-Dependent Stabilization of USP7 mRNA.

Leng Y, Liu Z, Min J, Ke Q, Shao Y, Lai J Biochem Genet. 2025; .

PMID: 39815132 DOI: 10.1007/s10528-024-10999-9.

References

Xu C, Wang X, Liu K, Roundtree I, Tempel W, Li Y . Structural basis for selective binding of m6A RNA by the YTHDC1 YTH domain. Nat Chem Biol. 2014; 10(11):927-9. DOI: 10.1038/nchembio.1654. View

Zhang Q, Riddle R, Yang Q, Rosen C, Guttridge D, Dirckx N . The RNA demethylase FTO is required for maintenance of bone mass and functions to protect osteoblasts from genotoxic damage. Proc Natl Acad Sci U S A. 2019; 116(36):17980-17989. PMC: 6731662. DOI: 10.1073/pnas.1905489116. View

Tong X, Chen X, Zhang S, Huang M, Shen X, Xu J . The Effect of Exercise on the Prevention of Osteoporosis and Bone Angiogenesis. Biomed Res Int. 2019; 2019:8171897. PMC: 6500645. DOI: 10.1155/2019/8171897. View

Scheller E, Rosen C . What's the matter with MAT? Marrow adipose tissue, metabolism, and skeletal health. Ann N Y Acad Sci. 2014; 1311:14-30. PMC: 4049420. DOI: 10.1111/nyas.12327. View

Salzman J . Circular RNA Expression: Its Potential Regulation and Function. Trends Genet. 2016; 32(5):309-316. PMC: 4948998. DOI: 10.1016/j.tig.2016.03.002. View

Guo M, Liu X, Zheng X, Huang Y, Chen X . mA RNA Modification Determines Cell Fate by Regulating mRNA Degradation. Cell Reprogram. 2017; 19(4):225-231. DOI: 10.1089/cell.2016.0041. View

Knuckles P, Lence T, Haussmann I, Jacob D, Kreim N, Carl S . Zc3h13/Flacc is required for adenosine methylation by bridging the mRNA-binding factor Rbm15/Spenito to the mA machinery component Wtap/Fl(2)d. Genes Dev. 2018; 32(5-6):415-429. PMC: 5900714. DOI: 10.1101/gad.309146.117. View

Muftic M, Selimovic E, Miladinovic K . Osteoporosis--comparative study between quantitative ultrasound of calcaneus and DXA. Med Arch. 2014; 67(4):289-91. DOI: 10.5455/medarh.2013.67.289-291. View

Shen G, Zhou H, Zhang H, Chen B, Liu Z, Yuan Y . The GDF11-FTO-PPARγ axis controls the shift of osteoporotic MSC fate to adipocyte and inhibits bone formation during osteoporosis. Biochim Biophys Acta Mol Basis Dis. 2018; 1864(12):3644-3654. DOI: 10.1016/j.bbadis.2018.09.015. View

10.

Huang H, Weng H, Chen J . mA Modification in Coding and Non-coding RNAs: Roles and Therapeutic Implications in Cancer. Cancer Cell. 2020; 37(3):270-288. PMC: 7141420. DOI: 10.1016/j.ccell.2020.02.004. View

11.

Chen X, Zhi X, Pan P, Cui J, Cao L, Weng W . Matrine prevents bone loss in ovariectomized mice by inhibiting RANKL-induced osteoclastogenesis. FASEB J. 2017; 31(11):4855-4865. PMC: 5636701. DOI: 10.1096/fj.201700316R. View

12.

Chen Q, Shou P, Zheng C, Jiang M, Cao G, Yang Q . Fate decision of mesenchymal stem cells: adipocytes or osteoblasts?. Cell Death Differ. 2016; 23(7):1128-39. PMC: 4946886. DOI: 10.1038/cdd.2015.168. View

13.

Kasowitz S, Ma J, Anderson S, Leu N, Xu Y, Gregory B . Nuclear m6A reader YTHDC1 regulates alternative polyadenylation and splicing during mouse oocyte development. PLoS Genet. 2018; 14(5):e1007412. PMC: 5991768. DOI: 10.1371/journal.pgen.1007412. View

14.

Lin S, Liu J, Jiang W, Wang P, Sun C, Wang X . METTL3 Promotes the Proliferation and Mobility of Gastric Cancer Cells. Open Med (Wars). 2019; 14:25-31. PMC: 6419388. DOI: 10.1515/med-2019-0005. View

15.

Yan G, Yuan Y, He M, Gong R, Lei H, Zhou H . mA Methylation of Precursor-miR-320/RUNX2 Controls Osteogenic Potential of Bone Marrow-Derived Mesenchymal Stem Cells. Mol Ther Nucleic Acids. 2020; 19:421-436. PMC: 6940653. DOI: 10.1016/j.omtn.2019.12.001. View

16.

Xu K, Yang Y, Feng G, Sun B, Chen J, Li Y . Mettl3-mediated mA regulates spermatogonial differentiation and meiosis initiation. Cell Res. 2017; 27(9):1100-1114. PMC: 5587845. DOI: 10.1038/cr.2017.100. View

17.

Shi H, Wei J, He C . Where, When, and How: Context-Dependent Functions of RNA Methylation Writers, Readers, and Erasers. Mol Cell. 2019; 74(4):640-650. PMC: 6527355. DOI: 10.1016/j.molcel.2019.04.025. View

18.

Wang Y, Zeng L, Liang C, Zan R, Ji W, Zhang Z . Integrated analysis of transcriptome-wide mA methylome of osteosarcoma stem cells enriched by chemotherapy. Epigenomics. 2019; 11(15):1693-1715. DOI: 10.2217/epi-2019-0262. View

19.

Bliuc D, Alarkawi D, Nguyen T, Eisman J, Center J . Risk of subsequent fractures and mortality in elderly women and men with fragility fractures with and without osteoporotic bone density: the Dubbo Osteoporosis Epidemiology Study. J Bone Miner Res. 2014; 30(4):637-46. DOI: 10.1002/jbmr.2393. View

20.

Wang H, Kuang M, Han S, Wang A, Qiu J, Wang F . BMP2 Modified by the mA Demethylation Enzyme ALKBH5 in the Ossification of the Ligamentum Flavum Through the AKT Signaling Pathway. Calcif Tissue Int. 2020; 106(5):486-493. DOI: 10.1007/s00223-019-00654-6. View